Abstract
West Nile virus (WNV) is a mosquito-borne, single-stranded, positive-sense RNA virus belonging to the Flaviviridae family. After WNV gains entry through an infected mosquito bite, it replicates in a variety of human cell types and produces a viremia. Although the majority of infected individuals remain asymptomatic, the manifested symptoms in some people range from a mild fever to severe neurological disorder with high morbidity and mortality. In addition, many who recover from WNV neuroinvasive infection present with long-term deficits, including weakness, fatigue, and cognitive problems. Since entering the USA in 1999, WNV has become the most common mosquito-borne virus in North America. Despite the intensive research over 20 years, there are still no approved vaccines or specific treatments for humans, and it remains an urgent need to understand the pathogenesis of WNV and develop specific therapeutics and vaccines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Mukhopadhyay S, Kim BS, Chipman PR et al (2003) Structure of West Nile virus. Science 302(5643):248. https://doi.org/10.1126/science.1089316
Markoff L (2003) 5′- and 3′-noncoding regions in flavivirus RNA. Adv Virus Res 59:177–228. https://doi.org/10.1016/s0065-3527(03)59006-6
Friebe P, Harris E (2010) Interplay of RNA elements in the dengue virus 5′ and 3′ ends required for viral RNA replication. J Virol 84(12):6103–6118. https://doi.org/10.1128/JVI.02042-09
Khromykh AA, Meka H, Guyatt KJ et al (2001) Essential role of cyclization sequences in flavivirus RNA replication. J Virol 75(14):6719–6728. https://doi.org/10.1128/JVI.75.14.6719-6728.2001
Shi PY, Brinton MA, Veal JM et al (1996) Evidence for the existence of a pseudoknot structure at the 3′ terminus of the flavivirus genomic RNA. Biochemistry 35(13):4222–4230. https://doi.org/10.1021/bi952398v
Acharya D, Bai F (2016) An overview of current approaches toward the treatment and prevention of West Nile virus infection. Methods Mol Biol 1435:249–291. https://doi.org/10.1007/978-1-4939-3670-0_19
Bai F, Thompson EA (2021) West Nile Virus (Flaviviridae). In: Bamford DH, Zuckerman M (eds) Encyclopedia of virology, 4th edn. Academic Press, Oxford, pp 884–890. https://doi.org/10.1016/B978-0-12-809633-8.21504-5
Westaway EG, Mackenzie JM, Khromykh AA et al (2002) Replication and gene function in Kunjin virus. Curr Top Microbiol Immunol 267:323–351. https://doi.org/10.1007/978-3-642-59403-8_16
Bai F, Town T, Pradhan D et al (2007) Antiviral peptides targeting the West Nile virus envelope protein. J Virol 81(4):2047–2055. https://doi.org/10.1128/JVI.01840-06
Grant D, Tan GK, Qing M et al (2011) A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. J Virol 85(15):7775–7787. https://doi.org/10.1128/JVI.00665-11
Wicker JA, Whiteman MC, Beasley DW et al (2006) A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology 349(2):245–253. https://doi.org/10.1016/j.virol.2006.03.007
Xie X, Wang QY, Xu HY et al (2011) Inhibition of dengue virus by targeting viral NS4B protein. J Virol 85(21):11183–11195. https://doi.org/10.1128/JVI.05468-11
Ramanathan MP, Chambers JA, Pankhong P et al (2006) Host cell killing by the West Nile virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology 345(1):56–72. https://doi.org/10.1016/j.virol.2005.08.043
Lindenbach BD, Rice CM (2001) Flaviviridae: the viruses and their replication. Fields’ Virol, 4th ed., pp. 991–1110
Ray D, Shah A, Tilgner M et al (2006) West Nile virus 5′-cap structure is formed by sequential guanine N-7 and ribose 2′-O methylations by nonstructural protein 5. J Virol 80(17):8362–8370. https://doi.org/10.1128/JVI.00814-06
Tan BH, Fu J, Sugrue RJ et al (1996) Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology 216(2):317–325. https://doi.org/10.1006/viro.1996.0067
Henderson BR, Saeedi BJ, Campagnola G et al (2011) Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme. PLoS One 6(10):e25795. https://doi.org/10.1371/journal.pone.0025795
Keating JA, Bhattacharya D, Lim PY et al (2013) West Nile virus methyltransferase domain interacts with protein kinase G. Virol J 10:242. https://doi.org/10.1186/1743-422X-10-242
Smithburn KC, Hughes TP, Burke AW et al (1940) A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 20:471–472. https://doi.org/10.4269/ajtmh.1940.s1-20.471
Bai F, Thompson EA, Vig PJS et al (2019) Current understanding of West Nile virus clinical manifestations, immune responses, Neuroinvasion, and immunotherapeutic implications. Pathogens. https://doi.org/10.3390/pathogens8040193
Spigland I, Jasinska-Klingberg W, Hofshi E et al (1958) Clinical and laboratory observations in an outbreak of West Nile fever in Israel in 1957. Harefuah 54(11):275–280. PMID: 13562703
Murgue B, Murri S, Triki H et al (2001) West Nile in the Mediterranean basin: 1950-2000. Ann N Y Acad Sci 951:117–126. https://doi.org/10.1111/j.1749-6632.2001.tb02690.x
Bin H, Grossman Z, Pokamunski S et al (2001) West Nile fever in Israel 1999-2000: from geese to humans. Ann N Y Acad Sci 951:127–142. https://doi.org/10.1111/j.1749-6632.2001.tb02691.x
Tsai TF, Popovici F, Cernescu C et al (1998) West Nile encephalitis epidemic in southeastern Romania. Lancet 352(9130):767–771. https://doi.org/10.1016/s0140-6736(98)03538-7
Gubler DJ (2007) The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 45(8):1039–1046. https://doi.org/10.1086/521911
Mann BR, McMullen AR, Swetnam DM et al (2013) Molecular epidemiology and evolution of West Nile virus in North America. Int J Environ Res Public Health 10(10):5111–5129. https://doi.org/10.3390/ijerph10105111
Centers for Disease Control and Prevention (CDC). West Nile virus disease cases and deaths reported to CDC by year and clinical presentation, 1999–2020. https://www.cdc.gov/westnile/statsmaps/cumMapsData.html
West Nile virus and other arboviral diseases-United States, 2012 (2013) MMWR Morb Mortal Wkly Rep 62(25):513–517. PMID: 23803959
Chancey C, Grinev A, Volkova E et al (2015) The global ecology and epidemiology of West Nile virus. Biomed Res Int 376230. https://doi.org/10.1155/2015/376230
Kaiser JA, Barrett ADT (2019) Twenty years of progress toward West Nile virus vaccine development. Viruses 11(9):823. https://doi.org/10.3390/v11090823
Kilpatrick AM, Daszak P, Jones MJ et al (2006) Host heterogeneity dominates West Nile virus transmission. Proc Biol Sci 273(1599):2327–2333. https://doi.org/10.1098/rspb.2006.3575
Reisen WK, Fang Y, Martinez VM et al (2005) Avian host and mosquito (Diptera: Culicidae) vector competence determine the efficiency of West Nile and St. Louis encephalitis virus transmission. J Med Entomol 42(3):367–375. https://doi.org/10.1093/jmedent/42.3.367
Kilpatrick AM, Kramer LD, Jones MJ et al (2006) West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol 4(4):e82. https://doi.org/10.1371/journal.pbio.0040082
Hamer GL, Kitron UD, Goldberg TL et al (2009) Host selection by Culex pipiens mosquitoes and West Nile virus amplification. Am J Trop Med Hyg 80(2):268–278. PMID: 19190226
Bowen RA, Nemeth NM (2007) Experimental infections with West Nile virus. Curr Opin Infect Dis 20(3):293–297. https://doi.org/10.1097/QCO.0b013e32816b5cad
Johnston LJ, Halliday GM, King NJ (2000) Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J Invest Dermatol 114(3):560–568. https://doi.org/10.1046/j.1523-1747.2000.00904.x
Kovats S, Turner S, Simmons A et al (2016) West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells. Clin Exp Immunol 186(2):214–226. https://doi.org/10.1111/cei.12850
Qian F, Wang X, Zhang L et al (2011) Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis 203(10):1415–1424. https://doi.org/10.1093/infdis/jir048
Acknowledgement
This work was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health R15AI135893 (F.B.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Karim, SU., Bai, F. (2023). Introduction to West Nile Virus. In: Bai, F. (eds) West Nile Virus. Methods in Molecular Biology, vol 2585. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2760-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2760-0_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2759-4
Online ISBN: 978-1-0716-2760-0
eBook Packages: Springer Protocols